Effect of age on the immunoglobulin class switch

Critical Reviews in Immunology

Volumn 24, Issue 5, 2004, Pages 297-320

  Frasca, Daniela ^a   Riley, Richard L ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Antibody production; B cells; Class switch recombination (CSR); Transcription factors

Indexed keywords

CYTIDINE DEAMINASE; DNA; GENE PRODUCT; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; INHIBITOR OF DIFFERENTIATION 2; LYMPHOCYTE SURFACE MARKER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BLIMP 1; TRANSCRIPTION FACTOR E47; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

AGED; AGING; ANTIBODY RESPONSE; B LYMPHOCYTE; GENE REARRANGEMENT; GENE SWITCHING; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN CELL; TRANSCRIPTION TERMINATION;

AGE FACTORS; AGING; ANIMALS; ANTIBODY FORMATION; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; DNA-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; MICE; NF-KAPPA B; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 19944430840     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v24.i5.10     Document Type: Review

References (203)

1. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A 2003;100(25):15053-8.
2. Hodes RJ. Aging and the immune system. Immunol Rev 1997;160:5-8.
3. Mountz JD, Wu J, Zhou T, Hsu HC. Cell death and longevity, implications of Fas-mediated apoptosis in T-cell senescence. Immunol Rev 1997;160:19-30.
4. LeMaoult J, Szabo P, Weksler ME. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev 1997;160:115-26.
5. Pawelec G, Solana R. Immunosenescence. Immunol Today 1997;18(11):514-6.
6. Weiss A, Miller LJ. Halting the march of the immune defenses. Science 1998;280(5361):179.
7. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5(2):133-9.
8. Steger MM, Maczek C, Berger P, Grubeck-Loebenstein B. Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection. Lancet 1996;348(9029):762.
9. Weksler ME, Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol 2000;20(4):240-9.
10. Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev 1997;160:55-62.
11. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 1997;160:63-77.
12. Klinman NR, Kline GH. The B-cell biology of aging. Immunol Rev 1997;160:103-14.
13. Komatsubara S, Cinader B, Muramatsu S. Functional competence of dendritic cells of ageing C57BL/6 mice. Scand J Immunol 1986;24(5):517-25.
14. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993;23(9):2375-8.
15. Wick G, Grubeck-Loebenstein B. Primary and secondary alterations of immune reactivity in the elderly, impact of dietary factors and disease. Immunol Rev 1997;160:171-84.
16. Aydar Y, Balogh P, Tew JG, Szakal AK. Follkular dendritic cells in aging, a "bottle-neck" in the humoral immune response. Ageing Res Rev 2004;3(1):15-29.
17. Plackert TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol 2004;76(2):291-9.
18. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4(2):112-24.
19. Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc Biol 1998;64(6):703-12.
20. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002;169(9):4697-701.
21. Smeal T, Guarente L. Mechanisms of cellular senescence. Curr Opin Genet Dev 1997;7(2):281-7.
22. Johnson FB, Sinclair DA, Guarente L. Molecular biology of aging. Cell 1999;96(2):291-302.
23. Imai S, Kitano H. Heterochromatin islands and their dynamic reorganization: a hypothesis for three distinctive features of cellular aging. Exp Gerontol 1998;33(6):555-70.
24. McHeyzer-Williams MG. B cells as effectors. Curr Opin Immunol 2003;15(3):354-61.
25. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298(5601):2199-202.
26. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 1997;160:63-77.
27. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997;388(6638):133-4.
28. Han S, Yang K, Ozen Z, Peng W, Marinova E, Kelsoe G, et al. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol 2003;170(3):1267-73.
29. Miller C, Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 1995;155(7):3377-84.
30. Banerjee M, Mehr R, Belelovsky A, Spencer J, Dunn-Walters DK. Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees. Eur J Immunol 2002;32(7):1947-57.
31. Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 1996;183(3):959-70.
32. Dunn-Walters DK, Banerjee M, Mehr R. Effects of age on antibody affinity maturation. Biochem Soc Trans 2003;31(2):447-8.
33. Rogerson BJ, Harris DP, Swain SL, Burgess DO. Germinal center B cells in Peyer's patches of aged mice exhibit a normal activation phenotype and highly mutated IgM genes. Mech Ageing Dev 2003;124(2):155-65.
34. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol 1975;22(1):84-90.
35. Zharhary D, Klinman NR. B cell repertoire diversity to PR8 influenza virus does not decrease with age. J Immunol 1984;133(5):2285-7.
36. Hu A, Ehleiter D, Ben-Yehuda A, Schwab R, Russo C, Szabo P, et al. Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol 1993;5(9):1035-9.
37. Miller C, Kelsoe G. Lack of B7.2 expression in the germinal centers of aged mice. Aging Immunol Infect Dis 1994;5:294-300.
38. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995;16(1):12-6.
39. Colonna-Romano G, Bulati M, Aquino A, Scialabba G, Candore G, Lio D, et al. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 2003;124(4):389-93.
40. Bartoloni C, Guidi L, Frasca D, Antico L, Pili R, Cursi F, et al. Immune parameters in a population of institutionalized elderly subjects: influence of depressive disorders and endocrinological correlations. Mech Ageing Dev 1991;60(1):1-12.
41. Bergler W, Adam S, Gross HJ, Hermann K, Schwartz-Albiez R. Age-dependent altered proportions in subpopulations of tonsillar lymphocytes. Clin Exp Immunol 1999;116(1):9-18.
42. De Martinis M, Modesti M, Loreto MF, Quaglino D, Ginaldi L. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci 2000;68(2):139-51.
43. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381(6585):751-8.
44. Patke A, Mecklenbrauker I, Tarakhovsky A. Survival signaling in resting B cells. Curr Opin Immunol 2004;16(3):251-5.
45. Weiss A, Gambier JC. Lymphocyte activation. Curr Opin Immunol 2004;16(3):285-7.
46. Reth M. The B-cell antigen receptor complex and co-receptors. Immunol Today 1995;16(7):310-3.
47. Gauld SB, Dal Porto JM, Gambier JC. B cell antigen receptor signaling: roles in cell development and disease. Science 2002;296(5573):1641-2.
48. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, et al. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med 1993;178(3):1049-55.
49. Kurosaki T. Functional dissection of BCR signaling pathways. Curr Opin Immunol 2000;12(3):276-81.
50. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410(6824):37-40.
51. Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002;2(12):945-56.
52. DeFranco AL. Signaling pathways activated by protein tyrosine phosphorylation in lymphocytes. Curr Opin Immunol 1993;6:364-371.
53. Monroe JG. Ligand-independent tonic signaling in B-cell receptor function. Curr Opin Immunol 2004;16(3):288-95.
54. DeFranco AL. Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr Opin Cell Biol 1995;7(2):163-75.
55. Janssen E, Zhang W. Adaptor proteins in lymphocyte activation. Curr Opin Immunol 2003;15(3):269-76.
56. Whisler RL, Liu BQ, Newhouse YG, Walters JD, Breckenridge MB, Grants IS. Signal transduction in human B cells during aging: alterations in stimulus-induced phosphorylations of tyrosine and serine/threonine substrates and in cytosolic calcium responsiveness. Lymphokine Cytokine Res 1991;10(6):463-73.
57. Whisler RL, Grants IS. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech Ageing Dev 1993;71(1-2):31-46.
58. Ahluwalia N, Sun J, Krause D, Mastro A, Handte G. Immune function is impaired in iron-deficient, homebound, older women. Am J Clin Nutr 2004;79(3):516-21.
59. Riley RL, Kruger MG, Elia J. B cell precursors are decreased in senescent BALB/c mice, but retain normal mitotic activity in vivo and in vitro. Clin Immunol Immunopathol 1991;59(2):301-13.
60. Szabo P, Shen S, Weksler ME. Age-associated defects in B lymphocyte development. Exp Gerontol 1999;34(3):431-4.
61. Sherwood EM, Blomberg BB, Xu W, Warner CA, Riley RL. Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment. J Immunol 1998;161(9):4472-5.
62. Sherwood EM, Xu W, King AM, Blomberg BB, Riley RL. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins. Mech Ageing Dev 2000;118(1-2):45-59.
63. Weksler ME. Changes in the B-cell repertoire with age. Vaccine 2000;18(16):1624-8.
64. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998;91(1):75-88.
65. Li F, Jin F, Freitas A, Szabo P, Weksler ME. Impaired regeneration of the peripheral B cell repertoire from bone marrow following lymphopenia in old mice. Eur J Immunol 2001;31(2):500-5.
66. Johnson SA, Rozzo SJ, Gambier JC. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol 2002;168(10):5014-23.
67. Callard RE, Basten A. Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol 1977;31(1):13-25.
68. Kishimoto S, Tomino S, Mitsuya H, Fujiwara H, Tsuda H. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans. J Immunol 1980;125(5):2347-52.
69. Zharhary D, Klinman NR. A selective increase in the generation of phosphorylcholine-specific B cells associated with aging. J Immunol 1986;136(2):368-70.
70. Sanchez M, Lindroth K, Sverremark E, Gonzalez Fernandez A, Fernandez C. The response in old mice: positive and negative immune memory after priming in early age. Int Immunol 2001;13(10):1213-21.
71. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993;150(2):543-9.
72. Riley SC, Froscher BG, Linton PJ, Zharhary D, Marcu K, Klinman NR. Altered VH gene segment utilization in the response to phosphorylcholine by aged mice. J Immunol 1989;143(11):3798-805.
73. Weksler ME, Russo C, Siskind GW. Peripheral T cells select the B-cell repertoire in old mice. Immunol Rev 1989;110:173-85.
74. Nicoletti C, Borghesi-Nicoletti C, Yang XH, Schulze DH, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J Immunol 1991;147(8):2750-5.
75. Yang X, Stedra J, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. IV. Study of VH and VL gene utilization in splenic antibody foci by in situ hybridization. J Immunol 1994;152(5):2214-21.
76. Ben-Yehuda A, Szabo P, LeMaoult J, Manavalan JS, Weksler ME. Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5+ B cells. Mech Ageing Dev 1998;103(2):111-21.
77. LeMaoult J, Delassus S, Dyall R, Nikolic-Zugic J, Kourilsky P, Weksler ME. Clonal expansions of B lymphocytes in old mice. J Immunol 1997;159(8):3866-74.
78. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5-B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004;103(6):2337-42.
79. Radl J. Age-related monoclonal gammapathies: clinical lessons from the aging C57BL mouse. Immunol Today 1990;11(7):234-6.
80. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131(1 Pt 1):47-54.
81. Notarangelo LD, Duse M, Ugazio AG. Immuno-deficiency with hyper-IgM (HIM). Immunodefic Rev 1992;3(2):101-21.
82. Bhushan A, Covey LR. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol Res 2001;24(3):311-24.
83. Durandy A. Hyper-IgM syndromes: a model for studying the regulation of dass switch recombination and somatic hypermutation generation. Biochem Soc Trans 2002;30(4):815-8.
84. Zhang Y, Wang Y, Liu L, Sweeney C, Tian L, Mbawuike I. Hypergammaglobulinemia and increased Bcl-2 expression on B cells in aged mice. In: AAI Meeting; 2003; Denver, CO; 2003. p. C290.
85. Goidl EA, Innes JB, Weksler ME. Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med 1976;144(4):1037-48.
86. Weksler MC, Innes JD, Goldstein G. Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36. J Exp Med 1978;148(4):996-1006.
87. Smith AM. The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol 1976;116(2):469-74.
88. Natsuume-Sakai S, Motonishi K, Migita S. Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. Immunology 1977;32(6):861-6.
89. Haaijman JJ, Van Den Berg P, Brinkhof J. Immunoglobulin class and subclass levels in the serum of CBA mice throughout life. Immunology 1977;32(6):923-7.
90. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002;37(2-3):427-39.
91. Arreaza EE, Gibbons JJ Jr, Siskind GW, Weksler ME. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans. Clin Exp Immunol 1993;92(1):169-73.
92. Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol 1992;90(2):351-4.
93. Paganelli R, Scala E, Quinti I, Ansotegui IJ. Humoral immunity in aging. Aging (Milano) 1994;6(3):143-50.
94. Rosenmann E, Rabinowitz R, Schlesinger M. Lymphocyte subsets in human tonsils: the effect of age and infection. Pediatr Allergy Immunol 1998;9(3):161-7.
95. Sen DK, Sarin GS, Mathur GP, Saha K. Biological variation of immunoglobulin concentrations in normal human tears related to age and sex. Acta Ophthalmol 1978;56(3):439-44.
96. Challacombe SJ, Perdval RS, Marsh PD. Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals. Oral Microbiol Immunol 1995;10(4):202-7.
97. Ebersole JL, Smith DJ, Taubman MA. Secretory immune responses in ageing rats. I. Immunoglobulin levels. Immunology 1985;56(2):345-50.
98. Schmucker DL, Owen RL, Outenreath R, Thoreux K. Basis for the age-related decline in intestinal mucosal immunity. Clin Dev Immunol 2003;10(2-4): 167-72.
99. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 1999;190(7):1013-24.
100. Steger MM, Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol 1996;105(3):544-50.
101. Aydar Y, Balogh P, Tew JG, Szakal AK. Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation. Eur J Immunol 2002;32(10):2817-26.
102. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002;168(5):2255-63.
103. Hilkens CM, Snijders A, Snijdewint FG, Wierenga EA, Kapsenberg ML. Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur Respir J Suppl 1996;22:90s-94s.
104. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999;286(5447):2156-9.
105. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004;197:179-91.
106. Forster I, Gu H, Muller W, Schmitt M, Tarlinton D, Rajewsky K. CD5 B cells in the mouse. Curr Top Microbiol Immunol 1991;173:247-51.
107. Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003;197(7):939-45.
108. Hallgren HM, Buckley CE III, Gilbertsen VA, Yunis EJ. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J Immunol 1973;111(4):1101-7.
109. Goidl EA, Choy JW, Gibbons JJ, Weksler ME, Thorbecke GJ, Siskind GW. Production of autoantiidiotypic antibody during the normal immune response. VII. Analysis of the cellular basis for the increased auto-antiidiotype antibody production by aged mice. J Exp Med 1983;157(5):1635-45.
110. Goidl EA, Samarut C, Schneider-Gadicke A, Hochwald NL, Thorbecke GJ, Siskind GW. Production of auto-anti-idiotypic antibody during the normal immune response. IX. Characteristics of the auto-anti-idiotype antibody and its production. Cell Immunol 1984;85(1):25-33.
111. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002;20:165-96.
112. Kaminski DA, Stavnezer J. Antibody class switching: uncoupling S region accessibility from transcription. Trends Genet 2004;20(8):337-40.
113. Stavnezer J. Immunology. A touch of antibody class. Science 2000;288(5468):984-5.
114. Petersen S, Casellas R, Reina-San-Martin B, Chen HT, Difilippantonio MJ, Wilson PC, et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001;414(6864):660-5.
115. Manis JP, Gu Y, Lansford R, Sonoda E, Ferrini R, Davidson L, et al. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 1998;187(12):2081-9.
116. Casellas R, Nussenzweig A, Wuerffel R, Pelanda R, Reichlin A, Suh H, et al. Ku80 is required for immunoglobulin isotype switching. EMBO J 1998;17(8):2404-11.
117. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999;274(26):18470-6.
118. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000;102(5):553-63.
119. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000;102(5):565-75.
120. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 2002;415(6873):802-6.
121. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 2002;416(6878):340-5.
122. Szocinski JL, Khaled AR, Hixon J, Halverson D, Funakoshi S, Fanslow WC, et al. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax. Blood 2002;100(1):217-23.
123. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76(6):959-62.
124. Dadgostar H, Zarnegar B, Hoffmann A, Qin XF, Truong U, Rao G, et al. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci USA 2002;99(3):1497-502.
125. Calderhead DM, Kosaka Y, Manning EM, Noelle RJ. CD40-CD154 interactions in B-cell signaling. Curr Top Microbiol Immunol 2000;245(2):73-99.
126. Ahonen C, Manning E, Erickson LD, O'Connor B, Lind EF, Pullen SS, et al. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 2002;3(5):451-6.
127. Zhu N, Ramirez LM, Lee RL, Magnuson NS, Bishop GA, Gold MR. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J Immunol 2002;168(2):744-54.
128. Pullen SS, Dang TT, Crute JJ, Kehry MR. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 1999;274(20):14246-54.
129. Jabara H, Laouini D, Tsitsikov E, Mizoguchi E, Bhan A, Castigli E, et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 2002;17(3):265-76.
130. Snapper CM, Finkelman FD, Stefany D, Conrad DH, Paul WE. IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide. J Immunol 1988;141(2):489-98.
131. Gronowicz ES, Doss C, Assisi F, Vitetta ES, Coffman RL, Strober S. Surface Ig isotypes on cells responding to lipopolysaccharide by IgM and IgG secretion. J Immunol 1979;123(5):2049-56.
132. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996;8(2):199-205.
133. Snapper CM, Kehry MR, Castle BE, Mond JJ. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy. J Immunol 1995;154(3):1177-87.
134. Frasca D, Van der Put E, Riley RL, Blomberg BB. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol 2004;172(4):2155-62.
135. Manis JP, Dudley D, Kaylor L, Alt FW. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 2002;16(4):607-17.
136. Sugai M, Gonda H, Kusunoki T, Katakai T, Yokota Y, Shimizu A. Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol 2003;4(1): 25-30.
137. Jeppson JD, Patel HR, Sakata N, Domenico J, Terada N, Gelfand EW. Requirement for dual signals by anti-CD40 and IL-4 for the induction of nuclear factor-kappa B, IL-6, and IgE in human B lymphocytes. J Immunol 1998;161(4):1738-42.
138. Whisler RL, Williams JW Jr, Newhouse YG. Human B cell proliferative responses during aging. Reduced RNA synthesis and DNA replication after signal transduction by surface immunoglobulins compared to B cell antigenic determinants CD20 and CD40. Mech Ageing Dev 1991;61(2):209-22.
139. Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 2002;169(8):4298-306.
140. Reina-San-Martin B, Difilippantonio S, Hanitsch L, Masilamani RF, Nussenzweig A, Nussenzweig MC. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med 2003;197(12):1767-78.
141. Ephrussi A, Church GM, Tonegawa S, Gilbert W. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 1985;227(4683):134-40.
142. Henthorn P, Kiledjian M, Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science 1990;247(4941):467-70.
143. Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu Rev Immunol 2002;20:301-22.
144. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000;20(2):429-40.
145. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 1989;56(5):777-83.
146. Schlissel M, Voronova A, Baltimore D. Helix-loophelix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev 1991;5(8):1367-76.
147. Sigvardsson M, O'Riordan M, Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surogate light chain genes. Immunity 1997;7:25-36.
148. Kee BL, Bain G, Murre C. IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J 2002;21(1-2):103-13.
149. Frasca D, Nguyen D, Riley RL, Blomberg BB. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J Immunol 2003;170(2):719-26.
150. Rivera R, Murre C. The regulation and function of the Id proteins in lymphocyte development. Oncogene 2001;20(58):8308-16.
151. Quong MW, Harris DP, Swain SL, Murre C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J 1999;18(22):6307-18.
152. Sayegh CE, Quong MW, Agata Y, Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003;4:586-593.
153. Frasca D, Nguyen D, Riley RL, Blomberg BB. Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells. Mech Ageing Dev 2003;124(4):361-9.
154. Bounpheng MA, Dimas JJ, Dodds SG, Christy BA. Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J 1999;13(15):2257-64.
155. Deed RW, Armitage S, Norton JD. Nuclear localization and regulation of Id protein through an E protein-mediated chaperone mechanism. J Biol Chem 1996;271(39):23603-6.
156. Frasca D, Nguyen D, Van der Put E, Riley RL, Blomberg BB. The age-related decrease in E47 DNA-binding does not depend on increased id inhibitory proteins in bone marrow-derived B cell precursors. Front Biosci 2003;8:a110-6.
157. Frasca D, Van Der Put E, Riley RL, Blomberg BB. Age-related differences in the E2A-encoded transcription factor E47 in bone marrow-derived B cell precursors and in splenic B cells. Exp Gerontol 2004;39(4):481-9.
158. Van Der Put E, Frasca D, King AM, Blomberg BB, Riley RL. Decreased e47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J Immunol 2004;173(2):818-27.
159. Kho CJ, Muggins GS, Endege WO, Hsieh CM, Lee ME, Haber E. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A. J Biol Chem 1997;272(6):3845-51.
160. Huggins GS, Chin MT, Sibinga NE, Lee SL, Haber E, Lee ME. Characterization of the mUBC9-binding sites required for E2A protein degradation. J Biol Chem 1999;274(40):28690-6.
161. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 1998;95(14):7987-92.
162. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995;20(11):465-70.
163. Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 2003;195(3):356-72.
164. Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D, et al. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 1996;156(1):183-91.
165. Saijo K, Mecklenbrauker I, Santana A, Leitger M, Schmedt C, Tarakhovsky A. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J Exp Med 2002;195(12):1647-52.
166. Tinnell SB, Jacobs-Helber SM, Sterneck E, Sawyer ST, Conrad DH. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production. Int Immunol 1998;10(10):1529-38.
167. Pioli C, Gatta L, Ubaldi V, Doria G. Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J Immunol 2000;165(10):5530-6.
168. Kaku H, Horikawa K, Obata Y, Kato I, Okamoto H, Sakaguchi N, et al. NF-kappaB is required for CD38-mediated induction of C(gamma)1 germline transcripts in murine B lymphocytes. Int Immunol 2002;14(9):1055-64.
169. Dedeoglu F, Horwitz B, Chaudhuri J, Alt FW, Geha RS. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int Immunol 2004;16(3):395-404.
170. Litinskiy MB, Nardelli B, Hubert DM, He B, Schaffer A, Casali P, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002;3(9):822-9.
171. Kim D, Xu M, Nie L, Peng XC, Jimi E, Voll RE, et al. Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. Immunity 2002;16(1):9-21.
172. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 2001;21(2):524-33.
173. Gonda H, Sugai M, Nambu Y, Katakai T, Agata Y, Mori KJ, et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 2003;198(9):1427-37.
174. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401(6753):556-62.
175. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 1998;17(8):2319-33.
176. Max EE, Wakatsuki Y, Neurath MF, Strober W. The role of BSAP in immunoglobulin isotype switching and B-cell proliferation. Curr Top Microbiol Immunol 1995;194:449-58.
177. Lin KI, Angelin-Dudos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 2002;22(13):4771-80.
178. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 1992;12(6):2662-72.
179. Zwollo P, Desiderio S. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. J Biol Chem 1994;269(21):15310-7.
180. Lauring J, Schlissel MS. Distinct factors regulate the marine RAG-2 promoter in B- and T-cell lines. Mol Cell Biol 1999;19(4):2601-12.
181. Neurath MF, Strober W, Wakatsuki Y. The murine Ig 3′ alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). J Immunol 1994;153(2):730-42.
182. Michaelson JS, Singh M, Birshtein BK. B cell lineage-specific activator protein (BSAP). A player at multiple stages of B cell development. J Immunol 1996;156(7):2349-51.
183. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002;17(1):51-62.
184. Kee BL, Murre C. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med 1998;188(4):699-713.
185. O'Riordan M, Grosschedl R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 1999;11(1):21-31.
186. Anspach J, Poulsen G, Kaattari I, Pollock R, Zwollo P. Reduction in DNA
187. Tell G, Scaloni A, Pellizzari L, Formisano S, Pucillo C, Damante G. Redoxpotential controls the structure and DNA binding activity of the paired domain. J Biol Chem 1998;273(39):25062-72.
188. Tell G, Zecca A, Pellizzari L, Spessotto P, Colombatti A, Kelley MR, et al. An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. Nucleic Acids Res 2000;28(5):1099-105.
189. Johnson K, Calame K. Transcription factors controlling the beginning and end of B-cell differentiation. Curr Opin Genet Dev 2003;13(5):522-8.
190. Tunyaplin C, Shaffer AL, Angelin-Dudos CD, Yu X, Staudt LM, Calame KL. Direct repression of prdml by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004;173(2):1158-65.
191. Knodel M, Kuss AW, Berberich I, Schimpl A. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur J Immunol 2001;31(7):1972-80.
192. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, et al. T cells and aging, January 2002 update. Front Biosci 2002;7:1056-183.
193. Miller RA. New paradigms for research on aging and late-life illness. Mech Ageing Dev 2001;122(2):130-2.
194. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002;168(11):5893-9.
195. Schwaiger S, Wolf AM, Robatscher P, Jenewein B, Grubeck-Loebenstein B. IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J Immunol 2003;170(1):613-9.
196. Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. Am J Epidemiol 1978;108(2):145-9.
197. Armitage KB, Dufry EG, Mincek MA, Miller CB, van der Kuyp F, Horn DL, et al. Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J Gerontol 1993;48(1):M19-25.
198. Haynes L, Eaton SM, Swain SL. The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine 2000;18(16):1649-53.
199. Frasca D, Pucci S, Goso C, Barattini P, Barile S, Pioli C, et al. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells. Mech Ageing Dev 1997;93(1-3):157-69.
200. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 2000;18(16):1629-37.
201. Klinman DM, Conover J, Bloom ET, Weiss W. Immunogenicity and efficacy of a DNA vaccine in aged mice. J Gerontol Ser A Biol Sci Med 1998;53:B281-B286.
202. Bender BS, Ulmer JB, DeWitt CM, Cottey R, Taylor SF, Ward AM, et al. Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice. Vaccine 1998;16(18):1748-55.
203. Saurwein-Teissl M, Schonitzer D, Grubeck-Loebenstein B. Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol 1998;33(6):625-31.